In his letter to the editor, Dr. Jaakko L.O. Pohjoismäki expressed his concern about our recent publication "Impaired Mitochondrial Biogenesis Precedes Heart Failure in Right Ventricular Hypertrophy in Congenital Heart Disease," 1 regarding the relationship between age and mtDNA copy number. Specifically, he suggested that the reported decrease of mtDNA levels in cardiac hypertrophy could be explained by the age differences of the patient groups rather than the status of the disease.
We appreciate the thoughtfulness of Dr. Pohjoismäki. Indeed, the median age of the control group in our study was older than the patient group, and the age range of the controls only partially overlaps with the age range of the patients (Table in the article) . However, the main focus of our study is on the mitochondrial biogenesis in hypertrophied right ventricle without clinical failure. This group of patients has considerable age overlap with the control group. We did not observe any age-dependent changes of mtDNA content and replication in nonfailing hearts between 4 to 18 years old, or in the RV hypertrophy group between 0.1 to 19 years old. In contrast, mtDNA content inversely correlated with the RV pressure ( Figure 6B ), which is an indicator of the severity of the cardiac stress. We also observed that in the RV hypertrophy, decreased mtDNA is associated with mitochondrial ultrastructural abnormalities ( Figure 5 ). Furthermore, decreased mtDNA content has been reported previously in adult human heart failure, 2 as well as in animal models, 3, 4 where the age of the controls and heart failure groups were matched. It is important to recognize that there is no consensus in the literature on whether mtDNA content changes from birth to adulthood in the human heart. While Dr. Pohjoismäki reported lower mtDNA in 4 infant samples, other studies have observed no difference of mtDNA copy number in the rodent or human hearts from neonates through aged subjects. 5, 6 It should also be mentioned that all of these studies used cardiac tissue from patients with some type or degree of heart disease. They were not true normal human heart tissues. Taken together, there is strong evidence that the decreased mtDNA we observed is attributable to the cardiac stress, and our findings in the pediatric patient population is supported by observations in adult heart failure studies. However, we agree that additional studies using tissues from normal infant hearts will help to draw the ultimate conclusions.
